Overall survival (OS) and forced vital capacity (FVC) results from the LUME-Meso study of nintedanib (N) plus pemetrexed/cisplatin (PEM/CIS) vs placebo (P) plus PEM/CIS in chemo-naive patients (pts) with malignant pleural mesothelioma (MPM)

S. Novello; A. K. Nowak; F. Grosso; N. Steele; S. Popat; L. Greillier; T. John; N. B. Leighl; M. Reck; N. Pavlakis; J. B. Sorensen; D. Planchard; G. L. Ceresoli; B. Hughes; J. Mazieres; M. A. Socinski; U. von Wangenheim; J. Barrueco; N. Morsli; G. Scagliotti

Overall survival (OS) and forced vital capacity (FVC) results from the LUME-Meso study of nintedanib (N) plus pemetrexed/cisplatin (PEM/CIS) vs placebo (P) plus PEM/CIS in chemo-naive patients (pts) with malignant pleural mesothelioma (MPM)

S. Novello
, A. K. Nowak
, F. Grosso
, N. Steele
, S. Popat
, L. Greillier
, T. John
, N. B. Leighl
, M. Reck
, N. Pavlakis
, J. B. Sorensen
, D. Planchard
, G. L. Ceresoli
, B. Hughes
, J. Mazieres
, M. A. Socinski
, U. von Wangenheim
, J. Barrueco
, N. Morsli
, G. Scagliotti

UWA Medical School

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

2 Citations (Web of Science)

Original language	English
Number of pages	2
Journal	Annals of Oncology
Volume	28
Publication status	Published - Sept 2017
Event	42nd European-Society-for-Medical-Oncology Congress (ESMO) - Madrid, Spain Duration: 8 Sept 2017 → 12 Sept 2017

Cite this

Novello, S., Nowak, A. K., Grosso, F., Steele, N., Popat, S., Greillier, L., John, T., Leighl, N. B., Reck, M., Pavlakis, N., Sorensen, J. B., Planchard, D., Ceresoli, G. L., Hughes, B., Mazieres, J., Socinski, M. A., von Wangenheim, U., Barrueco, J., Morsli, N., & Scagliotti, G. (2017). Overall survival (OS) and forced vital capacity (FVC) results from the LUME-Meso study of nintedanib (N) plus pemetrexed/cisplatin (PEM/CIS) vs placebo (P) plus PEM/CIS in chemo-naive patients (pts) with malignant pleural mesothelioma (MPM). Annals of Oncology, 28.

@article{b7ecdee2a6c94b41a9e8f51a90be4b1e,

title = "Overall survival (OS) and forced vital capacity (FVC) results from the LUME-Meso study of nintedanib (N) plus pemetrexed/cisplatin (PEM/CIS) vs placebo (P) plus PEM/CIS in chemo-naive patients (pts) with malignant pleural mesothelioma (MPM)",

author = "S. Novello and Nowak, \{A. K.\} and F. Grosso and N. Steele and S. Popat and L. Greillier and T. John and Leighl, \{N. B.\} and M. Reck and N. Pavlakis and Sorensen, \{J. B.\} and D. Planchard and Ceresoli, \{G. L.\} and B. Hughes and J. Mazieres and Socinski, \{M. A.\} and \{von Wangenheim\}, U. and J. Barrueco and N. Morsli and G. Scagliotti",

year = "2017",

month = sep,

language = "English",

volume = "28",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier",

note = "42nd European-Society-for-Medical-Oncology Congress (ESMO) ; Conference date: 08-09-2017 Through 12-09-2017",

}

Novello, S, Nowak, AK, Grosso, F, Steele, N, Popat, S, Greillier, L, John, T, Leighl, NB, Reck, M, Pavlakis, N, Sorensen, JB, Planchard, D, Ceresoli, GL, Hughes, B, Mazieres, J, Socinski, MA, von Wangenheim, U, Barrueco, J, Morsli, N & Scagliotti, G 2017, 'Overall survival (OS) and forced vital capacity (FVC) results from the LUME-Meso study of nintedanib (N) plus pemetrexed/cisplatin (PEM/CIS) vs placebo (P) plus PEM/CIS in chemo-naive patients (pts) with malignant pleural mesothelioma (MPM)', Annals of Oncology, vol. 28.

Overall survival (OS) and forced vital capacity (FVC) results from the LUME-Meso study of nintedanib (N) plus pemetrexed/cisplatin (PEM/CIS) vs placebo (P) plus PEM/CIS in chemo-naive patients (pts) with malignant pleural mesothelioma (MPM). / Novello, S.; Nowak, A. K.; Grosso, F. et al.
In: Annals of Oncology, Vol. 28, 09.2017.

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

TY - JOUR

T1 - Overall survival (OS) and forced vital capacity (FVC) results from the LUME-Meso study of nintedanib (N) plus pemetrexed/cisplatin (PEM/CIS) vs placebo (P) plus PEM/CIS in chemo-naive patients (pts) with malignant pleural mesothelioma (MPM)

AU - Novello, S.

AU - Nowak, A. K.

AU - Grosso, F.

AU - Steele, N.

AU - Popat, S.

AU - Greillier, L.

AU - John, T.

AU - Leighl, N. B.

AU - Reck, M.

AU - Pavlakis, N.

AU - Sorensen, J. B.

AU - Planchard, D.

AU - Ceresoli, G. L.

AU - Hughes, B.

AU - Mazieres, J.

AU - Socinski, M. A.

AU - von Wangenheim, U.

AU - Barrueco, J.

AU - Morsli, N.

AU - Scagliotti, G.

PY - 2017/9

Y1 - 2017/9

M3 - Abstract/Meeting Abstract

SN - 0923-7534

VL - 28

JO - Annals of Oncology

JF - Annals of Oncology

T2 - 42nd European-Society-for-Medical-Oncology Congress (ESMO)

Y2 - 8 September 2017 through 12 September 2017

ER -